Even as Johnson & Johnsons (New Brunswick, New Jersey) Cordis (Miami Lakes, Florida) unit was rolling out results of a three-year trial of its Cypher drug-eluting stent (DES) during the American College of Cardiology meeting, another study was being reported comparing Cypher with another DES being used in Europe.

Small study compares Cypher, Taxus events

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Recognizing, Managing, and Reporting Pediatric Sexual Abuse and Assault
Eleventh Circuit Affirms Jury Verdict of $2.5 Million for Mesh Device Plaintiff Despite Close Call on Statute of Limitations
Indiana Appellate Court Allows Case to Proceed Against Doctor Accused of Improperly Accessing Patients’ Medical Records
Malpractice Insurance Rates Increasing After Stable Period
Clinical Decision Software Highly Effective in OR